100ug-Anti-Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
Image number
5
Species reactivity
Human
Aplication
WB,IHC
Concentration
500ug/ml
Clonality
Rabbit polyclonal
Delivery condition
4℃ with ice bags
Sequence of immunogen
TAFI (Glu138~Val423)
Organism Species
Homo sapiens (Human)
Source
Polyclonal antibody preparation
Item Name
Thrombin Activatable Fibrinolysis Inhibitor
Applicable Secondary Antibody
SAA544Rb59, SAA544Rb58, SAA544Rb57, SAA544Rb18, SAA544Rb19
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Immunogen
RPA615Hu01-Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
Alternative Names
CPB2; CPU; PCPB; Carboxypeptidase B2; Plasma Carboxypeptidase B; Carboxypeptidase U
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Storage instructions
Avoid repeated freeze/thaw cycles. Store at 4 ℃ for frequent use. Aliquot and store at -20℃ for 12 months.
Description
This antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided.Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.